Rochester, MNNCT06192875Now EnrollingIRB Ready

Hematopoietic and Lymphoid System Neoplasm Clinical Trial in Rochester, MN

Access cutting-edge hematopoietic and lymphoid system neoplasm treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.

Sponsored by Mayo Clinic

Quick Self-Assessment

See if you qualify for this Rochester location

Preparing your pre-screening questions…

Expert Care in Rochester

Access hematopoietic and lymphoid system neoplasm specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hematopoietic and lymphoid system neoplasm treatment provided free

Apply for This Rochester Location

Check if you qualify for this hematopoietic and lymphoid system neoplasm clinical trial in Rochester, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rochester

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rochester site if eligible
  4. 4Begin participation

About This Hematopoietic and Lymphoid System Neoplasm Study in Rochester

This study is being done to establish "normal' values for a new blood test and urine test approach to cancer screening. Patients undergo blood and urine sample collection on study. Patients' medical records are reviewed.

Sponsor: Mayo Clinic

Who Can Participate

Inclusion Criteria

10,000 patients without a known internal (non-cutaneous) cancer or a history of an internal cancer
To balance age, rough recruitment goals will be set for the following subsets: 18-39 years, 40-49 years , 50-59 years , 60-69 years , 70-79 years , and \>= 80 years
To balance sex, roughly half of the participants recruited within each age subset will be women
Roughly half of all participants will have had a colonoscopy or colon x-ray within the past 5 years, or Cologuard® test in the last 3 years which were negative for cancer and precancerous lesions
Roughly half of all participants will have had a chest x-ray within the past 5 years which was negative for cancer
Roughly half of women participants will have had a mammography in the past 5 years which was negative for cancer
An attempt will be made to recruit minimums (parentheses) of the following subsets: men with normal Prostate-specific antigen (PSA) level (200); diabetes mellitus (200); connective tissue diseases like rheumatoid arthritis, systemic lupus erythematosus, and scleroderma (100); chronic obstructive lung disease (100); inflammatory bowel disease or cirrhosis (100), and pancreatitis (100)
To assess the effects of other common covariates, specific recruitment targets will not be set. Rather, data obtained on all participants will include BMI, smoking (past/present), alcohol consumption, pregnant status (women), and selected medications (steroidal and non-steroidal anti-inflammatory drugs, statins, anti-hypertensives, and anti-depressants)

Exclusion Criteria

Patients has a past or current diagnosis of invasive cancer (this does not include basal cell or squamous cell skin cancers)
Patient has had a solid organ transplant
Inability to give informed consent URINE EXCLUSIONS
Patient has transurethral instrumentation (cystoscopy, placement of urinary catheter) within the 7 days prior to sample collection
Patient has chronic indwelling urinary catheter
Patient has had a urinary tract infection within the 14 days prior to sample collection SALIVA EXCLUSIONS
Patient has known clinically significant xerostomia
Patient has known recent (within 30 days prior to collection) active upper respiratory tract infection or anogenital infection

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rochester?

Yes, this clinical trial (NCT06192875) has an active research site in Rochester, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hematopoietic and Lymphoid System Neoplasm Treatment Options in Rochester, MN

If you're searching for hematopoietic and lymphoid system neoplasm treatment options in Rochester, MN, this clinical trial (NCT06192875) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hematopoietic and lymphoid system neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hematopoietic and lymphoid system neoplasm clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Rochester, MN

See all essential tremor clinical trials recruiting in Rochester — not just this study.

Browse Essential Tremor Trials in Rochester →

Ready to Join in Rochester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rochester, MN